| Identification | Back Directory | [Name]
Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indol-3-yl)-N-(3S)-3-piperidinyl-5-(trifluoromethyl)- | [CAS]
2750638-94-7 | [Synonyms]
CDK7-IN-12
Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indol-3-yl)-N-(3S)-3-piperidinyl-5-(trifluoromethyl)- | [Molecular Formula]
C20H19F3N6 | [MOL File]
2750638-94-7.mol | [Molecular Weight]
400.4 |
| Hazard Information | Back Directory | [Uses]
CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1]. | [References]
[1] Jing Wang, et al. Heterocyclic compounds and their derivatives. Patent WO2021249417A1. |
|
|